Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Improving Care for Heart Failure With Reduced Ejection Fraction—A Potential Polypill-Based Strategy

Improving Care for Heart Failure With Reduced Ejection Fraction—A Potential Polypill-Based Strategy This Viewpoint proposes that a polypill combination of a β-blocker, renin angiotensin inhibitor, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter 2 inhibitor might be the most efficient way to deliver guideline-directed HFrEF therapy, and proposes a research roadmap to design and evaluate the pill and implementation strategies for getting it to patients. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Improving Care for Heart Failure With Reduced Ejection Fraction—A Potential Polypill-Based Strategy

JAMA , Volume 324 (22) – Dec 8, 2020

Loading next page...
 
/lp/american-medical-association/improving-care-for-heart-failure-with-reduced-ejection-fraction-a-NOoOPxBVd5
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2020.21395
Publisher site
See Article on Publisher Site

Abstract

This Viewpoint proposes that a polypill combination of a β-blocker, renin angiotensin inhibitor, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter 2 inhibitor might be the most efficient way to deliver guideline-directed HFrEF therapy, and proposes a research roadmap to design and evaluate the pill and implementation strategies for getting it to patients.

Journal

JAMAAmerican Medical Association

Published: Dec 8, 2020

Keywords: polycap,heart failure with reduced ejection fraction,oral contraceptives,mineralocorticoid receptor antagonists

References